RecruitingNot Applicable

Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision

Greece44 participantsStarted 2021-09-19

Plain-language summary

The purpose of this research protocol is the evaluation of the improvement of the anorectal and urogenital urinary function, alongside the postoperative quality of life after the application of pIONM in patients submitted to TME for rectal cancer.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histologically confirmed rectal cancer * Surgical resection with TME * \<90 years old * Signed informed consent Exclusion Criteria: * Emergency operation * Presence of pacemaker * Partial mesorectal excision * Sepsis or systematic infection * Physical or mental impairment * Pregnancy or nursing * Insufficient preoperative data for the urogenital/ anorectal function * Lack of compliance with the research process

What they're measuring

Change in the quality of life of the patient at 3 months postoperatively, based on the SF-36 questionnaire

Timeframe: Preoperatively, 3 months postoperatively

Trial details

NCT IDNCT04949646

SponsorLarissa University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09-19

Contact for this trial

Konstantinos Tepetes, Prof

00302413502804 tepetesk@gmail.com

View on ClinicalTrials.gov More Rectal Neoplasms trials